Evidence map›Paper›PMID 34504248›Full record

ArticleScientific reports2021

Pentahydroxy flavonoid isolated from Madhuca indica ameliorated adjuvant-induced arthritis via modulation of inflammatory pathways.

Yongliang Tang, Daotao Xie, Wenqing Gong, Hongtao Wu, Yi Qiang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Anti-Arthritis Effect of Ethanol Extract of Sacha Inchi (Tropical life sciences research · 2023
    Article
  4. Anti-arthritic efficacy ofBioinformation · 2023
    Article
  5. Pharmaceutical chemistry journal · 2023
    Article
  6. Phenolic-Compound-RichNutrients · 2022
    Article
  7. Deciphering the pharmacological mechanisms ofFood science & nutrition · 2022
    Article
  8. Article
  9. Article
  10. Molecules (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Yongliang TangDepartment of Orthopaedics, Xi'an Jiaotong University, Xi'an, 710000, China.
Daotao XieDepartment of Technology, Shaanxi Nuoxing Youchuang Medical Research Center, Xi'an, 710032, China.
Wenqing GongDepartment of Ultrasound, Xijing Hospital, the Fourth Military Medical University, Xi'an, 710032, China.
Hongtao WuDepartment of Gynecology, Xianyang Central Hospital, Xianyang, 712000, China.
Yi QiangDepartment of Orthopaedics, The Affiliated Hospital of Northwest University, Xi'an No. 3 Hospital, Xi'an, 710018, China. coke44pjy@sina.com.
Air Force Medical University · CNNorthwest University · CNXi'an Jiaotong University · CNXian Yang Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is an autoimmune disease associated with advanced joint dysfunction. Madhuca indica J. F. Gmel, from the family Sapotaceae, is an Indian medicinal plant reported to have an array of pharmacological properties. The aim of present investigation was to determine the anti-arthritic potential of an isolated phytoconstituent from methanolic leaf extract of Madhuca indica (MI-ALC) against FCA-induced experimental arthritis. Polyarthritis was induced in female rats (strain: Wistar) via an intradermal injection of FCA (0.1 mL) into the tail. Polyarthritis developed after 32 days of FCA administration. Then rats were treated orally with an isolated phytoconstituent from MI-ALC at doses of 5, 10, and 20 mg/kg. Findings suggested that High-Performance Thin-Layer Chromatography, Fourier-Transform Infrared Spectroscopy, and Liquid Chromatography-Mass Spectrometry spectral analyses of the phytoconstituent isolated from MI-ALC confirmed the structure as 3,5,7,3',4'-Pentahydroxy flavone (i.e., QTN). Treatment with QTN (10 and 20 mg/kg) showed significant (p < 0.05) inhibition of increased joint diameter, paw volume, paw withdrawal threshold, and latency. The elevated synovial oxidative stress (Superoxide dismutase, reduced glutathione, and malondialdehyde) and protein levels of Tumor necrosis factor-α (TNF-α) and Interleukin (ILs) were markedly (p < 0.05) reduced by QTN. It also effectively (p < 0.05) ameliorated cyclooxygenase-2 (COX-2), Nuclear factor of kappa light polypeptide gene enhancer in B cells (NF-kβ) and its inhibitor-α (Ikβα), and ATP-activated P2 purinergic receptors (P2X7) protein expressions as determined by western blot analysis. In conclusion, QTN ameliorates FCA-induced hyperalgesia through modulation of elevated inflammatory release (NF-kβ, Ikβα, P2X7, and COX-2), oxido-nitrosative stress, and pro-inflammatory cytokines (ILs and TNF-α) in experimental rats.

Indexed as

Adjuvants, ImmunologicAdministration, OralAnimalsAntirheumatic AgentsArthritis, ExperimentalArthritis, RheumatoidCyclooxygenase 2CytokinesFemaleFlavonoidsFreund's AdjuvantHyperalgesiaMadhucaMolecular StructureNF-kappa BNitrosative StressAdjuvants, ImmunologicAntirheumatic AgentsCyclooxygenase 2CytokinesFlavonoidsFreund's AdjuvantNF-kappa BPlant ExtractsPtgs2 protein, rat

Identifiers

PMID34504248
PMCPMC8429448
OpenAlexW3198252837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.